Alpha Cognition (ACOG) News
NASDAQ: ACOGHealthcareBiotechnologyUSD
9.00+0.15 (+1.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ACOG news summary
We found 5 recent headlines mentioning Alpha Cognition (ACOG): 1 in the past week and 5 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ACOG is up 1.69% at $9.00. The most recent story, "Is Novartis (NVS) Outperforming Other Medical Stocks This Year?", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Alpha Cognition headlines
- Is Novartis (NVS) Outperforming Other Medical Stocks This Year?Here is how Novartis (NVS) and Alpha Cognition Inc. (ACOG) have performed compared to their sector so far this year.NasdaqNVS, ACOG
- Alpha Cognition (ACOG) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Alpha Cognition Inc. Reports Third Quarter 2026 Financial Results and Provides Operational UpdateVANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing and…Business Wire
- Halozyme Therapeutics (HALO) Tops Q3 Earnings and Revenue EstimatesHalozyme Therapeutics (HALO) delivered earnings and revenue surprises of +4.37% and +2.27%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the…NasdaqHALO, ACOG
- Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business UpdateVANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today…Business Wire